Definitive Contract HHSN261200511009C
Award Date 1/15/05
Potential Completion Date 1/14/10
Potential Value $76M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Rosedale, KS 66103, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
15
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This is a federal contract award from the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services. The contract, valued at $13,911,788.38, was awarded to the Cancer Prevention Institute of California to provide cancer information services. The contract type is Cost Plus Fixed Fee, and the period of performance extends from January 15, 2005, to January 14, 2010. This contract is not associated with any set-aside program.</p>
- This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Duke University's Office of Research Administration Division. The contract, valued at $19,856,652.14, is for the provision of the Cancer Information Service. The contract does not have a set-aside designation. Duke University serves as the prime contractor for this definitive, cost-no-fee contract, which has an ultimate completion date of January 14, 2010. The...
- This is a $123,015,908.00 cost-reimbursement contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract is for the Cancer Information Service, with an ultimate completion date of March 14, 2010. There is no set-aside designation for this contract. The Sloan-Kettering Institute for Cancer Research has previously served as a...
- This is a $4,559,338.00 cost-no-fee definitive contract awarded to the University of Kansas (KU) by the National Cancer Institute, a civilian agency. The contract is for the development of dosage forms and delivery systems for antitumor agents. As a major public research university and U.S. state government entity, KU has a strong track record of supporting federal initiatives through prime contracts, grants, and subcontracts. This contract does not have a set-aside designation, reflecting...
- This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to the International Union Against Cancer (UICC), a non-profit organization. The purpose of this $542,725.00 definitive contract is to facilitate international scientific cooperation in cancer research through the exchange visits of scientists. The contract is not set-aside. It began on September 30, 2009 and is scheduled to be completed by September 29, 2014. The contract aims to promote the direct and...
- This is a federal contract award from the National Cancer Institute (NCI), a division of the National Institutes of Health (NIH), to Fox Chase Cancer Center, a non-profit hospital. The contract, titled "CANCER INFORMATION SERVICE", has a ceiling value of $19,632,116.00 and is a definitive contract with cost-no-fee pricing. The contract does not have a set-aside designation. The contract was awarded on January 15, 2005 with a planned completion date of January 14, 2010. Fox Chase Cancer...
- This is a federal contract award to Health Research, Inc. (HRI), a non-profit organization, by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS). The $9,057,202.00 Definitive Contract is for Research and Development (R&D) and Other R&D activities, with a completion date of February 29, 2008. The contract is a Cost No Fee type and does not have a set-aside designation. HRI has a diverse portfolio of federal contracts and grants...
- The federal contract award with ID HHSN261200533000C was issued by the National Cancer Institute, a civilian agency of the U.S. Department of Health and Human Services, to the University of Oklahoma Univ Of Oklahoma Health Sciences Center Division. The contract, valued at $19,658,911.55, is for preclinical efficacy and intermediate endpoint assays. It is a definitive, cost-no-fee contract without a set-aside designation. The University of Oklahoma, as the prime contractor, will provide a range...
- This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of California, Davis (UC Davis) for early-stage therapeutic development with a focus on Phase II clinical trials. The $34,176,737.26 definitive cost-reimbursement contract was awarded on January 1, 2006 with a period of performance through February 20, 2015. The contract did not have a small business set-aside. UC Davis, a major public research...
- This federal contract award was made by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The award, valued at $1,076,616.60, is for Scientific Support Services for a Medical Officer 9 to support the Office of Sponsor and Regulatory Oversight within the NCI's Center for Cancer Research. The contract is a Blanket Purchase Agreement (BPA) Call issued under the Multiple Award Schedule (MAS) contract vehicle,...